Drugs for Age-Related Hearing Loss (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):
(show all 28)
# |
|
Name |
Status |
Phase |
Clinical Trials |
Cas Number |
PubChem Id |
1 |
|
Duloxetine |
Approved |
Phase 4 |
|
136434-34-9, 116539-59-4 |
60835 |
Synonyms:
(+-)-duloxetine
(3S)-N-Methyl-3-(1-naphthyloxy)-3-(2-thienyl)propan-1-amine
(S)-duloxetine
ARICLAIM
Cymbalta
Cymbalta®|LY248686
DUCILTIA
Duloxetina
Duloxetine
Duloxetine ethanedioate (1:1), (+-)-isomer - T353987
Duloxetine HCL
Duloxetine hydrochloride
|
Duloxetine, (+)-isomer
HCL, Duloxetine
Hydrochloride, duloxetine
LY 248686
LY248686
LY-248686
LY248686 HCL
LY-248686 HCL
N-Methyl-3-(1-naphthalenyloxy)-2-thiophenepropanamine
N-Methyl-3-(1-naphthalenyloxy)-3-(2-thiophene)propanamide
Yentreve
|
|
2 |
|
Dopamine |
Approved |
Phase 4 |
|
62-31-7, 51-61-6 |
681 |
Synonyms:
2-(3,4-Dihydroxyphenyl)ethylamine
3,4 Dihydroxyphenethylamine
3,4-Dihydroxyphenethylamine
3,4-Dihydroxyphenylethylamine
3-Hydroxytyramine
4-(2-Aminoethyl)-1,2-benzenediol
4-(2-Aminoethyl)benzene-1,2-diol
4-(2-Aminoethyl)catechol
4-(2-Aminoethyl)pyrocatechol
4-(2-Aminoethyl)-pyrocatechol
4-(2-AZANYLETHYL)BENZENE-1,2-DIOL
a-(3,4-Dihydroxyphenyl)-b-aminoethane
alpha-(3,4-Dihydroxyphenyl)-beta-aminoethane
ASL-279
CARBILEV
Deoxyepinephrine
Dopamin
Dopamina
DOPAMINE
DOPAMINE HCL
|
Dopamine hydrochloride
DOPAMIN-NATTERMAN
Dopaminum
Dopastat
Dophamine
DOPMIN
Dynatra
Hydrochloride, dopamine
Hydroxytyramin
Hydroxytyramine
Intropin
Medopa
NSC-169105
NSC-173182
Oxytyramine
PARCOPA
Revivan
SABAX DOPAMIN
SELECTAJET
SINEMET
|
|
3 |
|
Norepinephrine |
Approved |
Phase 4 |
|
51-41-2 |
439260 |
Synonyms:
(-)-(R)-Norepinephrine
(-)-alpha-(Aminomethyl)protocatechuyl alcohol
(−)-arterenol
(-)-Arterenol
(−)-noradrenaline
(-)-Noradrenaline
(−)-norepinephrine
(-)-Norepinephrine
(-)-norepinephrine|Levarterenol®|noradrenaline
(R)-(−)-norepinephrine
(R)-(-)-Norepinephrine
(R)-4-(2-amino-1-hydroxyethyl)-1,2-benzenediol
(R)-noradrenaline
(R)-norepinephrine
4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol
4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol
4-[(1R)-2-AMINO-1-HYDROXYETHYL]BENZENE-1,2-DIOL
4-[(1R)-2-AMINO-1-HYDROXY-ETHYL]BENZENE-1,2-DIOL
4-[(1R)-2-AMINO-1-HYDROXY-ETHYL]PYROCATECHOL
Adrenor
Aktamin
Arterenol
L-2-amino-1-(3,4-Dihydroxyphenyl)ethanol
|
L-3,4-Dihydroxyphenylethanolamine
L-alpha-(Aminomethyl)-3,4-dihydroxybenzyl alcohol
L-Arterenol
Levarterenol
Levoarterenol
Levonor
Levonoradrenaline
Levonorepinephrine
Levophed
L-noradrenaline
L-Norepinephrine
Noradrenalin
Noradrenaline
Nor-adrenaline
Norartrinal
Norepinefrina
Norepinephrine
Norépinéphrine
Norepinephrinum
Norepirenamine
Nor-epirenan
R-NOREPINEPHRINE
Sympathin E
|
|
4 |
|
Citalopram |
Approved |
Phase 4 |
|
59729-32-7, 59729-33-8 |
2771 |
Synonyms:
[<sup>3</sup>H]-citalopram
Akarin
Bonitrile
Celapram
Celexa
Celexa®|Cipramil®|LU-10171B
Celius
Ciazil
Cilift
Cipram
CIPRAMIL
Ciprapine
Citabax
Citadur
Citalec
Citalopram
Citalopram hydrobromide
Citalopramum
Citalopramum [INN-Latin]
Citol
Citopam
Citox
|
Citrol
Cytalopram
Dalsan
Elopram
Escitalopram
Escitalopram oxalate
Humorup
Lexapro
LU 10-171-B
LU-10-171-B
Nitalapram
Oropram
PAXORAN
Pramcit
Recital
Seropram
Talam
Talohexal
Temperax
Vodelax
Zentius
Zetalo
|
|
5 |
|
Dexetimide |
Withdrawn |
Phase 4 |
|
21888-98-2 |
30843 |
Synonyms:
(+)-BENZETIMIDE
(+)-benzetimide|R 16470|Tremblex®
Dexetimida
DEXETIMIDE
|
Dexetimidum
R 16470
R-16470 [AS HYDROCHLORIDE]
TREMBLEX
|
|
6 |
|
Neurotransmitter Agents |
|
Phase 4 |
|
|
|
7 |
|
Dopamine Agents |
|
Phase 4 |
|
|
|
8 |
|
Psychotropic Drugs |
|
Phase 4 |
|
|
|
9 |
|
Antidepressive Agents |
|
Phase 4 |
|
|
|
10 |
|
Serotonin Uptake Inhibitors |
|
Phase 4 |
|
|
|
11 |
|
Serotonin and Noradrenaline Reuptake Inhibitors |
|
Phase 4 |
|
|
|
12 |
|
Analgesics |
|
Phase 4 |
|
|
|
13 |
|
Serotonin |
Investigational, Nutraceutical |
Phase 4 |
|
50-67-9 |
5202 |
Synonyms:
3-(2-Aminoethyl)-1H-indol-5-ol
3-(2-Aminoethyl)indol-5-ol
3-(b-Aminoethyl)-5-hydroxyindole
5 Hydroxytryptamine
5-HT
5-HT|serotonin
5-HTA
5-Hydroxy-3-(b-aminoethyl)indole
5-Hydroxyltryptamine
5-Hydroxytriptamine
5-Hydroxytryptamine
5-Hydroxy-tryptamine
|
Antemovis
DS Substance
Enteramin
Enteramine
Hippophaine
Hydroxytryptamine
SEROTONIN
Serotonine
sérotonine
Thrombocytin
Thrombotonin
|
|
14 |
|
Estradiol |
Approved, Investigational, Vet_approved |
|
|
50-28-2 |
5757 |
Synonyms:
(+)-3,17B-ESTRADIOL
(17b)-Estra-1,3,5(10)-triene-3,17-diol
(17BETA)-ESTRA-1,3,5(10)-TRIENE-3,17-DIOL
(17Β)-ESTRA-1,3,5(10)-TRIENE-3,17-DIOL
(1S,10R,11S,14S,15S)-15-METHYLTETRACYCLO[8.7.0.0^{2,7}.0^{11,15}]HEPTADECA-2,4,6-TRIENE-5,14-DIOL
(8R,9S,13S,14S,17S)-13-METHYL-6,7,8,9,11,12,14,15,16,17-DECAHYDROCYCLOPENTA[A]PHENANTHRENE-3,17-DIOL
[<sup>3</sup>H]-estradiol|[<sup>3</sup>H]-estrogen|[<sup>3</sup>H]E2|[<sup>3</sup>H]estradiol
13B-METHYL-1,3,5(10)-GONATRIENE-3,17B-OL
17 beta Estradiol
17 beta Oestradiol
17 beta-Estradiol
17 beta-Oestradiol
17b Oestradiol
17b-Estra-1,3,5(10)-triene-3,17-diol
17B-ESTRADIOL
17BETA OESTRADIOL
17BETA-ESTRA-1,3,5(10)-TRIENE-3,17-DIOL
17BETA-ESTRADIOL
17BETA-OESTRADIOL
17B-OESTRADIOL
17Β oestradiol
17Β-ESTRA-1,3,5(10)-TRIENE-3,17-DIOL
17β-estradiol
17Β-OESTRADIOL
3,17B-DIHYDROXYESTRA-1,3,5(10)-TRIENE
3,17B-ESTRADIOL
3,17-EPIDIHYDROXYESTRATRIENE
ADGYN ESTRO
AERODIOL
AGOFOLLIN
ALFATRADIOL
ALORA
ALTRAD
AMNESTROGEN
AQUADIOL
AQUAGEN
BARDIOL
BEDOL
B-ESTRADIOL
BETA-ESTRADIOL
CIS-ESTRADIOL
CLIMADERM
CLIMARA
CLIMARA PRO
COMPUDOSE
CORPAGEN
Delestrogen
DELTA-ESTRADIOL
DELTA-OESTRADIOL
DEPO-ESTRADIOL
DERMESTRIL
DERMESTRIL 100
DERMESTRIL 25
DERMESTRIL 50
DERMESTRIL SEPTEM 25
DERMESTRIL SEPTEM 50
DERMESTRIL SEPTEM 75
DESTRADIOL
D-ESTRADIOL
DIHYDROFOLLICULAR HORMONE
DIHYDROFOLLICULIN
DIHYDROMENFORMON
DIHYDROTHEELIN
DIHYDRO-THEELIN
DIHYDROXYESTRIN
DIMENFORMON
DIOGYN
DIOGYNETS
DIVIGEL
D-OESTRADIOL
E2
E2|estrogen|oestrodiol|oestrogen
E-CYPIONATE
ELESTRIM
ELESTRIN
ELLESTE SOLO
ELLESTE SOLO MX 40
ELLESTE SOLO MX 80
ENCORE
EPIESTRIOL 50
ESCLIM
ESTRA-1,3,5(10)-TRIENE-3,17B-DIOL
ESTRACE
ESTRADERM
ESTRADERM MX 100
ESTRADERM MX 25
ESTRADERM MX 50
ESTRADERM MX 75
ESTRADERM TTS
ESTRADERM TTS 100
ESTRADERM TTS 25
ESTRADERM TTS 50
ESTRADIOL
Estradiol 17 alpha
Estradiol 17 beta
Estradiol 17beta
Estradiol anhydrous
ESTRADIOL HEMIHYDRATE
Estradiol hemihydrate, (17 alpha)-isomer
Estradiol monohydrate
Estradiol orion brand
Estradiol valerate
Estradiol valeriante
|
Estradiol, (-)-isomer
Estradiol, (+-)-isomer
Estradiol, (16 alpha,17 alpha)-isomer
Estradiol, (16 alpha,17 beta)-isomer
Estradiol, (17-alpha)-isomer
Estradiol, (8 alpha,17 beta)-(+-)-isomer
Estradiol, (8 alpha,17 beta)-isomer
Estradiol, (9 beta,17 alpha)-isomer
Estradiol, (9 beta,17 beta)-isomer
Estradiol, monosodium salt
Estradiol, sodium salt
Estradiol-17 alpha
Estradiol-17 beta
Estradiol-17b
ESTRADIOL-17BETA
ESTRADIOL-17-BETA
Estradiol-17β
ESTRADIOLUM
ESTRADOT
ESTRALDINE
ESTRASORB
ESTRING
ESTRING VAGINAL RING
ESTROCLIM
ESTROCLIM 50
ESTROGEL
ESTROGEL HBF
ESTROGEN
ESTROVITE
EVAMIST
EVOREL
EVOREL 100
EVOREL 25
EVOREL 50
EVOREL 75
FEMATRIX 40
FEMATRIX 80
FEMESTRAL
FEMOGEN
FEMPATCH
FEMSEVEN 100
FEMSEVEN 50
FEMSEVEN 75
FOLLICYCLIN
GELESTRA
GINOSEDOL
GVNODIOL
GYNERGON
GYNODIOL
GYNOESTRYL
GYNOGEN
IMVEXXY
INNOFEM
LAMDIOL
MACRODIOL
MENOREST
MENOREST 37.5
MENOREST 50
MENOREST 75
MENORING 50
MENOSTAR
MINIVELLE
NORDICOL
Novartis pharmaceuticals brand OF estradiol
NSC-20293
NSC-9895
OESCLIM
OESTERGON
OESTRA-1,3,5(10)-TRIENE-3,17B-DIOL
OESTRADIOL
OESTRODIOL
OESTROGEL
OESTROGEN
OESTROGLANDOL
Orion brand OF estradiol
OVAHORMON
OVASTEROL
OVASTEVOL
OVOCYCLIN
OVOCYLIN
PERLATANOL
PRIMOFOL
PROFOLIOL
PROFOLIOL B
PROGYNON
Progynon depot
PROGYNON DH
Progynon-depot
Progynova
PROGYNOVA TS
SANDRENA
SANDRENA 1
SYNDIOL
SYSTEN
VAGIFEM
VAGIFEM 18
VAGIFEM 8
VIVELLE
VIVELLE-DOT
WC3011
WC-3011
ZUMENON
Β-estradiol
|
|
15 |
|
Polyestradiol phosphate |
Approved |
|
|
28014-46-2 |
|
Synonyms:
(17-beta)-Estra-1,3,5(10)-triene-3,17-diol polymer with phosphoric acid
ESTRADIOL PHOSPHATE
Estradiol phosphate polymer
ESTRADURIN
Fosfato de poliestradiol
LEO-114
Oestradiol phosphate polymer
|
Phosphate de polyestradiol
Poly(estradiol phosphate)
POLYEST PHOS
POLYESTRADIOL PHOS PHOSPHATE
POLYESTRADIOL PHOSPHATE
Polyestradioli phosphas
|
|
16 |
|
Ethanol |
Approved |
|
|
64-17-5 |
702 |
Synonyms:
[CH2Me(OH)]
[OEtH]
1-Hydroxyethane
ABLYSINOL
Absolute alcohol
Absolute ethanol
Absolute ethyl alcohol
Aethanol
Aethylalkohol
Alcare hand degermer
Alcohol
Alcohol (ethyl)
Alcohol anhydrous
Alcohol denatured
ALCOHOL DETERMINATION--ALCOHOL
Alcohol etilico
Alcohol etílico
Alcohol, absolute
Alcohol, Dehydrated
Alcohol, denatured
ALCOHOL, DILUTED
Alcohol, ethyl
Alcohol, grain
ALCOHOL, RUBBING
Alcohols
Alcool ethylique
Alcool éthylique
Alcool etilico
Algrain
Alkohol
Alkoholu etylowego
Aminoethanol
Anhydrol
Anhydrous alcohol
Anhydrous ethanol
Äthanol
Äthylalkohol
B3324
Beta-Aminoethanol
Beta-Aminoethyl Alcohol
Beta-Ethanolamine
Beta-Hydroxyethylamine
C2H5OH
Caswell No. 426
Colamine
Cologne spirit
Cologne spirits
Dehydrated alcohol
Dehydrated ethanol
Denatured alcohol
Denatured Alcohol Cd-10
Denatured Alcohol Cd-5
Denatured Alcohol Cd-5a
Denatured Alcohol Sd-1
Denatured Alcohol Sd-13a
Denatured Alcohol Sd-17
Denatured Alcohol Sd-23a
Denatured Alcohol Sd-28
Denatured Alcohol Sd-30
Denatured Alcohol Sd-39b
Denatured Alcohol Sd-39c
Denatured Alcohol Sd-3a
Denatured Alcohol Sd-40m
Denatured ethanol
Desinfektol el
Diluted alcohol
Distilled spirits
DRINKING ALCOHOL
E1510
Envision Conditioner Pdd 9020
ETA
Etanol
|
Etanolo
ETHANOL
éthanol
Ethanol 200 proof
Ethanol Absolute
Ethanol Absolute Bp
Ethanol Anhydrous
Ethanol Extra Pure
Ethanol solution
Ethanol, Silent Spirit
Ethicap
Ethyl alc
Ethyl alcohol
Ethyl Alcohol & Water, 10%
Ethyl Alcohol & Water, 20%
Ethyl Alcohol & Water, 30%
Ethyl Alcohol & Water, 40%
Ethyl Alcohol & Water, 5%
Ethyl Alcohol & Water, 50%
Ethyl Alcohol & Water, 60%
Ethyl Alcohol & Water, 70%
Ethyl Alcohol & Water, 80%
Ethyl Alcohol & Water, 95%
Ethyl Alcohol & Water, 96%
Ethyl alcohol anhydrous
Ethyl alcohol in alcoholic beverages
Ethyl alcohol usp
Ethyl Alcohol, Anhydrous
Ethyl Alcohol, Denatured
Ethyl hydrate
Ethyl hydroxide
Ethylol
Ethylolamine
EtOH
FEMA NO. 2419
Fermentation alcohol
Glycinol
Grain alcohol
Hinetoless
HSDB 531
Hydroxyethane
Infinity pure
Jaysol
Jaysol S
Lux
METHYLATED MINERAL
Methylated Spirit Mineralised
Methylcarbinol
Molasses alcohol
NCI-C03134
NSC-85228
PM-6193-200
Potato alcohol
Punctilious ethyl alcohol
Pyro
Reagent Alcohol
Silent spirit
SPIRIGEL
Spirit
Spirits OF wine
Spiritus vini
Spirt
SURG
Synasol
Tecsol
Tecsol C
Thanol
Thiofaco M-50
Undenatured ethanol
USAF EK-1597
VODKA
|
|
17 |
|
Huperzine A |
Approved, Experimental |
|
|
102518-79-6 |
|
Synonyms:
(−)-huperazine A
(−)-selagine
Huperzine-A
|
|
|
18 |
|
Estradiol 3-benzoate |
|
|
|
|
|
19 |
|
Estradiol 17 beta-cypionate |
|
|
|
|
|
20 |
|
Hormones |
|
|
|
|
|
21 |
|
Hormone Antagonists |
|
|
|
|
|
22 |
|
Anti-Retroviral Agents |
|
|
|
|
|
23 |
|
Pharmaceutical Solutions |
|
|
|
|
|
24 |
|
Astragalus |
|
|
|
|
|
25 |
|
Neuroprotective Agents |
|
|
|
|
|
26 |
|
Cholinesterase Inhibitors |
|
|
|
|
|
27 |
|
Cholinergic Agents |
|
|
|
|
|
28 |
|
Protective Agents |
|
|
|
|
|
Interventional clinical trials:
(show all 50)
# |
Name |
Status |
NCT ID |
Phase |
Drugs |
1 |
Sensation and Psychiatry: Linking Age-Related Hearing Loss to Late-Life Depression and Cognitive Decline |
Completed |
NCT03321006 |
Phase 4 |
Duloxetine or escitalopram |
2 |
A Balanced, Randomized, Placebo-Controlled, Double-Blind Study of the Efficacy and Safety of AUT00063 Versus Placebo in Age-Related Hearing Loss [CLARITY-1 Study] |
Completed |
NCT02345031 |
Phase 2 |
AUT00063;Placebo |
3 |
Audiology Visits After Screening for Hearing Loss: An RCT |
Completed |
NCT00105742 |
Phase 2 |
|
4 |
RCT Study of Liuwei Dihuang Pill Preventing and Treating Presbycusis With Shen (Kidney)-Yin Deficiency |
Recruiting |
NCT05125081 |
Phase 2 |
Liuwei Dihuang Pill (marketed product in China);Liuwei Dihuang Pill(placebo ) |
5 |
A Phase 1b, Prospective, Randomized, Double-Blind, Placebo-Controlled, Single-Dose, Multicenter, Safety Study of FX-322 Administered by Intratympanic Injection in Adults With Age-Related Sensorineural Hearing Loss |
Completed |
NCT04601909 |
Phase 1 |
FX-322 |
6 |
The Repeatable Battery for the Assessment of Neuropsychological Status for Hearing Impaired Individuals (RBANS-H) in Older Adults With Normal Hearing or Age-related Hearing Loss |
Unknown status |
NCT03208608 |
|
|
7 |
Use of Hearing Aids. Development and Implementation of a Counselling Program for Hearing Aid Users. |
Unknown status |
NCT02233361 |
|
|
8 |
Clinical Trial on Cognitive, Behavioural, Quality of Life and Medico-economic Benefits of Hearing Aids in Alzheimer Disease Patients Suffering From Presbycusis |
Completed |
NCT00488007 |
|
|
9 |
Age-Related Hearing Loss: Presbycusis & Its Neural Bases |
Completed |
NCT00264407 |
|
Hormone Replacement Therapy - HRT |
10 |
Impact of Hearing Aid Technology on Self-reported Outcomes in Patients With Presbycusis - a Randomized Controlled Trial |
Completed |
NCT04539847 |
|
|
11 |
Evaluation of Efficacy and Patient Acceptance of Sound Amplifier Téo First, in Mild and Moderate Presbycusis Patient 60 Years of Age and Older, With no Previous Hearing Aid. |
Completed |
NCT01815788 |
|
|
12 |
Neurological Treatment to Improve the Hearing in Noise Abilities of Older Adults With Hearing Impairments. |
Completed |
NCT02147847 |
|
|
13 |
At-home Auditory Training Clinical Trial |
Completed |
NCT01950013 |
|
|
14 |
Clinical and Imaging Biomarkers of Audiovestibular Function in Infratentorial Superficial Siderosis |
Completed |
NCT04200664 |
|
|
15 |
Speech-in-Noise Measures as a Predictor of Hearing Aid Outcomes |
Completed |
NCT00371449 |
|
|
16 |
Characterizing Variability in Hearing Aid Outcomes Among Older Adults |
Completed |
NCT02448706 |
|
|
17 |
Pilot Study of the Links Between Presbyacusis and Lexical Disorders in Patients With Alzheimer's Disease or Related Disease |
Completed |
NCT03638323 |
|
|
18 |
Assessment of e-Audiology for Providing Clinical Services and Support for Age-related Hearing Loss: A Pilot Study |
Completed |
NCT04048460 |
|
|
19 |
Genetic Study of Age Related Hearing Loss |
Completed |
NCT01732289 |
Early Phase 1 |
|
20 |
Evaluating Hearing Aid Service Delivery Models |
Completed |
NCT01788423 |
|
|
21 |
Investigation Of the Effects Of Dual-Task And Single-Task Training In Older Adults With Age-Related Hearing Loss |
Completed |
NCT05190081 |
|
|
22 |
Assessment of Age-related Hearing Loss in HIV-1 Patients |
Completed |
NCT02154971 |
|
|
23 |
Immediate Effects of Personal Sound Amplification Products on Speech Processing |
Completed |
NCT05076045 |
|
|
24 |
The Baltimore HEARS Pilot Study: Hearing Health Care Equality Through Accessible Research & Solutions |
Completed |
NCT02045511 |
|
|
25 |
Baltimore HEARS Study: Addressing Hearing Impairment and Social Engagement Through Community-delivered Hearing Care |
Completed |
NCT03442296 |
|
|
26 |
Consequences of Aging and Dirtying of Microphones on the Performances of Cochlear Implants. Influence of Signal Coding |
Completed |
NCT02369718 |
|
|
27 |
Adaptation and Pilot Implementation of the Family Check-Up for Deaf and Hard of Hearing Children |
Completed |
NCT03483428 |
|
|
28 |
A Parent-Directed, Multimedia Early Intervention Tool to Improve Outcomes in Underserved Children Who Are Deaf or Hard-of-Hearing |
Completed |
NCT01753661 |
|
|
29 |
Study of the Association Between Presbycusis With the Incidence of Frailty. Intake of Polyphenols for the Prevention of Presbycusis: Effects on Frailty |
Recruiting |
NCT04360109 |
|
|
30 |
Mitochondrial Genetics of Presbycusis |
Recruiting |
NCT03720964 |
|
|
31 |
Impact of Hearing Aid Intervention on Individuals With Cognitive Disorders |
Recruiting |
NCT04049643 |
|
|
32 |
Cost-effective Hearing Aid Delivery Models: Outcomes, Value, and Candidacy |
Recruiting |
NCT03579563 |
|
|
33 |
Impact of Auditory Stimulation in Eating Pleasure : Multicentric Study With Biscuits With Crunchy Texture vs Soft Texture in 100 Seniors Affected or at Risk of Presbyacusis |
Recruiting |
NCT04923087 |
|
|
34 |
Longitudinal Outcomes of Over-the-Counter Hearing Aids |
Recruiting |
NCT04030299 |
|
|
35 |
Evaluation of Unilateral vs Bilateral Hearing Aids for the Treatment of Age-related Hearing Loss |
Recruiting |
NCT04739436 |
|
|
36 |
HearCARE: Hearing for Communication and Resident Engagement |
Recruiting |
NCT04575051 |
|
|
37 |
Evaluation of the Hearing Aids Efficacy in Elderly Subjects: a Protocol for Multiparametric Longitudinal Study |
Recruiting |
NCT04333043 |
|
|
38 |
Development of a Battery of Audiological Tests for the Precision Diagnosis of Age-related Hearing Loss |
Recruiting |
NCT05312983 |
|
|
39 |
Longitudinal Evaluation of Hearing Aids Rehabilitation Within Age-related Hearing Loss Population : Behavioral and Neuroimaging PET Evaluations. |
Recruiting |
NCT05331404 |
|
|
40 |
Training Cognition to Improve Mobility and Listening in Older Adults With Hearing Loss: Moving From Lab to Life |
Recruiting |
NCT05418998 |
|
|
41 |
Improving Outcomes Using Augmentative and Alternative Communication for Children Who Are Deaf or Hard of Hearing |
Recruiting |
NCT02998164 |
|
|
42 |
Behavioral Parent Training for Families With Deaf and Hard of Hearing Preschoolers |
Recruiting |
NCT03916146 |
|
|
43 |
Technology-assisted Language Intervention for Children Who Are Deaf/Hard-of-hearing (TALI) |
Recruiting |
NCT04857255 |
|
|
44 |
Teletherapy to Address Language Disparities in Deaf and Hard-of-hearing Children |
Recruiting |
NCT04928209 |
|
|
45 |
Hearing Loss and Communication Needs in a Group Care Setting for Older Adults |
Active, not recruiting |
NCT04659967 |
|
|
46 |
Effects of Huperzine A on Presbycusis-related Subjective Tinnitus and Cognitive Impairment |
Enrolling by invitation |
NCT03101722 |
|
BTHE and Huperzine A |
47 |
Evaluation of the Impact of Cochlear Implants on Cognition in Older Adults |
Enrolling by invitation |
NCT02729402 |
|
|
48 |
Increasing Word Learning Efficiency in Children Who Are Deaf and Hard of Hearing Through Retrieval Practice |
Not yet recruiting |
NCT05512000 |
|
|
49 |
Effects of Cognitive Training on Age-Related Hearing Loss and Speech Perception |
Terminated |
NCT02294812 |
|
|
50 |
Objective Measurement of Hearing Aid Benefit |
Withdrawn |
NCT04431622 |
|
|
|